Amsterdam, The Netherlands Monday, June 23, 2025, 12:00 Hrs [IST] ...

Nanoform secures €5 million R&D loan from Business Finland to advance clinical development of nanoapalutamide: Helsinki, Finland Monday, June 23, 2025, 11:00 Hrs [IST] Nanoform ...

UK MHRA approves Accord Healthcare’s anti-PD-1 monoclonal antibody, serplulimab to treat aggressive form of SCLC: United Kingdom Monday, June 23, 2025, 09:00 Hrs [IST] The Medic ...

Shardul Nautiyal, Mumbai Monday, June 23, 2025, 08:00 Hrs [IST] ...

Telangana IDMA eyes growth strategies of Gujarat & Maharashtra to replicate in local pharma sector: Peethaambaran Kunnathoor, Chennai. Monday, June 23, 2025, 08:00 Hrs [IST] Altho ...

Even though the Central government had revised the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) for the pharma industry last year, it remains toothless and statutorily unbinding, ...

FDI inflow into hospitals & diagnostic centres grew 4 per cent in FY25: Gireesh Babu, New Delhi Monday, June 23, 2025, 08:00 Hrs [IST] The Foreign Direct Investment (FDI) equity i ...

PCI asks institutions to submit appeal regarding statutory documents for AY25-26: Gireesh Babu, New Delhi Saturday, June 21, ...

Refeyn announces USP recognizes mass photometry in new AAV reference standards for gene therapy quality: Oxford, UK Friday, ...

CereVasc receives Health Canada investigational testing authorization to conduct STRIDE trial to evaluate eShunt System: Boston Saturday, June 21, 2025, 14:00 Hrs [IST] CereVasc I ...

KARL STORZ US gets expanded indication for Solo+ Tympanostomy tube device to use in pediatric patients aged 6 to 24 months old: El Segundo, California Saturday, June 21, 2025, 17: ...

Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML: Houston Saturday, June 21, 2025, 15:00 Hrs [IST] Moleculin Biotech ...